Clinical trials
Enrolling by invitation Breast Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 5 |
| 2025 | 8 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 3 |
| Affiliated Hospital of Jiangnan University | 2 |
| Fudan University | 2 |
| Caigang Liu | 1 |
| Guangdong Provincial Hospital of Traditional Chinese Medicine | 1 |
| Hunan Cancer Hospital | 1 |
| Jinan Central Hospital | 1 |
| Peking University | 1 |
| Taizhou Hospital | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 15 |
| Carcinoma, Transitional Cell | 2 |
| Stomach Neoplasms | 2 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.